Health Condition 1: O141- Severe pre-eclampsia
Conditions
Interventions
Intervention1: Optic Nerve Sheath Diameter measurement in severe preeclamptic patient: Procedure ONSD Measurement
Patient will be in supine position
7 and 15 MHz Linear array transducer will be used
Sponsors
TEERTHANKAR MAHAVEER MEDICAL COLLEGE
Eligibility
Inclusion criteria
Inclusion criteria: Parturients giving written informed consent, Antenatal patient diagnosed to have severe pre-eclampsia Patient about to receive Magnesium Sulphate therapy.
Exclusion criteria
Exclusion criteria: Chronic hypertension Hyperthyroidism High myopicPresence of ocular wound Prior ocular surgery Presence of oliguria and deranged KFT
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Optic nerve sheath diameter will be measuremed transorbitally by ultrasound in severe preeclamptic patient and will be compared with optic nerve sheath diameter at different time intervals after administration of MgSO4 treatment.Timepoint: just prior to start of MgSO4 therapy and at 2hr, 4hr, 6hr,12hrs and 24 hrs after start of therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Haemodynamic changes following MgSo4 theray Neurological signs and symptoms before and following MgSO4 therapy. Incidence of raised ICP in severe pre-eclampsia prior to and after MgSO4 therapy. Timepoint: just prior to start of MgSO4 therapy and at2hr, 4hr, 6hrs,12hrs and 24 hrs after start of therapy. | — |
Countries
India
Contacts
Public ContactDr Mukesh Kumar Prasad
TEERTHANKAR MAHAVEER MEDICAL COLLEGE
Outcome results
None listed